A Bayesian dosing method for carboplatin given by continuous infusion for 120 h.

Guillet, P; Monjanel, S; Nicoara, A; Duffaud, F; Lacarelle, B; Bagarry-Liegey, D; Durand, A; Catalin, J; Favre, R

Guillet, P; Monjanel, S; Nicoara, A; Duffaud, F; Lacarelle, B; Bagarry-Liegey, D; Durand, A; Catalin, J; Favre, R.

Affiliation

Guillet P; Service d'oncologie médicale, CHU Timone Adultes, Marseille, France.

Cancer Chemother Pharmacol ; 40(2): 143-9, 1997.

Article in En | MEDLINE | ID: mdl-9182836

Subject(s)

Antineoplastic Agents/administration & dosage; Bayes Theorem; Carboplatin/administration & dosage; Adult; Aged; Antineoplastic Agents/pharmacokinetics; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Carboplatin/pharmacokinetics; Drug Administration Schedule; Drug Tolerance; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms/drug therapy; Platinum/blood

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Bayes Theorem / Carboplatin / Antineoplastic Agents Type of study: Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 1997 Document type: Article Affiliation country: France Country of publication: Germany

Search on Google

Add to My VHL

XML

PubMed Links